𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab + CHOP beneficial in elderly with B-cell lymphoma

Book ID
120853818
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2005
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CHOP Chemotherapy plus Rituximab Compare
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
✍ Coiffier, Bertrand; Lepage, Eric; BriΓ¨re, Josette; Herbrecht, Raoul; Tilly, Herv πŸ“‚ Article πŸ“… 2002 πŸ› Massachusetts Medical Society 🌐 English βš– 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct